Forbes January 7, 2021
Bruce Japsen

Walgreens Boots Alliance plans to use billions of dollars in proceeds from the sale of its pharmaceutical wholesale business on developing its pharmacies for the future, the company’s chief executive said.

Money for drugstore development will come after the large drug wholesaler AmerisourceBergen said it will acquire the majority of Walgreens Boots Alliance’s “Alliance Healthcare” wholesale distribution business for $6.5 billion, the companies said Wednesday. Part of those proceeds will be used to invest in Walgreens pharmacies, which are adding new healthcare items, primary care services and new digital capabilities.

“We will invest in developing our pharmacies,” Walgreens chief executive Stefano Pessina said in an interview after the AmerisourceBergen deal was announced.

“Part of the money will be used to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
Pharmacies Should Adopt Proactive Health, Wellness to Help Patients
Advancing Healthcare Solutions: Harnessing Collaborative Business Models for Oncology
AI Identifies New Potential Treatments For Parkinson’s Disease

Share This Article